谷氨酰氨基肽酶 Glutamyl aminopeptidase
人亮氨酰氨基肽酶 LAP ; Human LAP ; Human Leucine aminopepridase,LAP ; LAP ELISA Kit
尿丙氨酸氨基肽酶 UAAP ; Urine alanimino peptideose AAP
膜内氨酰氨基肽酶 ANPEP
亮氨酰氨基肽酶 LAP ; Leucyl aminopeptidase
精氨酰氨基肽酶 RNPEP
氨基肽酶N Aminopeptidase
白氨酸氨基肽酶 leucine aminopeptidase
丙氨酸氨基肽酶 alanine aminopeptidase ; AAP
尿亮氨酰氨基肽酶 ULAP
Initially it is found that ubenimex is a potent inhibitor of aminopeptidase B~ N and Ieucine aminopeptidase.
最初观察到的乌苯美司生物活性是对细胞膜表面的氨基酸肽酶B、N和亮氨酸氨基肽酶的抑制作用。
参考来源 - 乌苯美司诱导绒癌JAR细胞凋亡的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
目的建立甘氨酰脯氨酰二肽氨基肽酶（GPDA）自动化分析方法。
Objective To establish a kinetic monitoring assay for detecting glycylproline dipeptidyl aminopeptidase (GPDA). Methods Gly-pro-pNA.
目的探讨应用连续监测法测定尿亮氨酸氨基肽酶(lap)及其临床应用价值。
Objective to study the continuous monitoring method determining leucine aminopeptidase (LAP) and its clinical application.
目的探讨尿亮氨酸氨基肽酶(LAP)筛查糖尿病和高血压病早期肾损害的临床价值。
Objective To study the role of urine leucine aminopeptidase (LAP) for sifting early renal injury in diabetic and hypertension patients.
应用推荐